Lastly, metformin notably increased the quantity of CD11c+ cells within the tumor environment (p = 0.002); however, it decreased the proportion of iNOS+ (p = 0.002) CD11c+ cells isolated from the tumor (Figure 5I,J). This evidence concerns the gene NOS2 and neoplasm.